Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BioChaperone Glucagon vs GlucaGen in T1DM
NCT03176524Phase 1Completed
- Sponsor
- Adocia
- Start
- Jun 2017
- Primary completion
- Sep 2017
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of biochaperone glucagon in hypoglycemia (3 arms), sponsored by Adocia. Primary endpoint: Clinical safety laboratory, Physical examination, ECG, Vital signs, Adverse events, Local tolerability up to 10 weeks. Started Jun 2017; status: completed.
02
Drugs
biochaperone glucagon
03
Conditions
hypoglycemia
Beyond the preview
Go deeper on NCT03176524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03176524.